Medical device makerLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA files no records under this name; these are its 3 companies' records, each linked to the record.
As of Nov 13, 2026, FDA's public records list GC Corporation and its 3 subsidiaries with 154 510(k) clearances and 1 warning letter. The most recent is a 510(k) clearance dated Sep 10, 2026: Cerasmart Forte.
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date, GC Corporation and its 3 subsidiaries
A hatched bar is a year that is not over, so its count covers only part of the year.
| Date | Record | Source |
|---|---|---|
| Sep 10, 2026 | Cerasmart ForteK262202 · EBF | 510(k) clearances |
| Jul 6, 2026 | Cytrans™ ElashieldK253317 · LYC | 510(k) clearances |
| Jun 18, 2026 | SRGC-06K261246 · EBF | 510(k) clearances |
| May 18, 2026 | G-CEM UNIVERSALK254109 · EMA | 510(k) clearances |
| May 14, 2026 | Warning letter: Data integrity, Stability, Supplier controlsCDER | Warning letters |
| Oct 2, 2025 | G-Bond UniversalK251124 · KLE | 510(k) clearances |
| Sep 19, 2025 | EQUIA LC ONEK250953 · EMA | 510(k) clearances |
| Aug 29, 2025 | G aenial Universal Injectable IIK251946 · EBF | 510(k) clearances |
| Nov 24, 2020 | G-CEM ONEK200798 · EMA | 510(k) clearances |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built
